发明名称 |
A pharmaceutical composition for treating hepatitis B virus (HBV) infection |
摘要 |
The invention provides a pharmaceutical composition for the treatment of hepatitis B virus (HBV) infection, comprising an amount of a soluble active agent which interacts with at least one of the binding sites between hIL6 and pS1 and between hIL6 and hepatocytes and other HBV-permissive cells, the active agent being present in sufficient amount to competitively bind to at least one of the sites and thereby to prevent hIL6-mediated HBV infection of hepatocytes and other HBV-permissive cells. |
申请公布号 |
AU8704998(A) |
申请公布日期 |
1998.09.08 |
申请号 |
AU19980087049 |
申请日期 |
1998.02.10 |
申请人 |
HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT COMPANY LTD. |
发明人 |
|
分类号 |
A61K38/00;A61K38/17;A61K38/20;A61K39/395;A61K47/48;A61P31/20;C07K14/715;C07K16/24;C07K16/28 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|